Abstract
Malignant hyperthermia is a hypermetabolic crisis of unregulated calcium accumulation and muscle activation in response to halogenated volatile anesthetics and succinylcholine. It is most frequently caused by mutations in the ryanodine receptor, a calcium channel in the sarcoplasmic reticulum of myocytes. Symptoms include masseter muscle spasm, generalized muscle rigidity, hypercarbia, a mixed metabolic and respiratory acidosis, hyperthermia, hyperkalemia, rhabdomyolysis, myoglobinuria, arrhythmias, and cardiovascular collapse. Management consists of dantrolene, supportive care, and avoidance of triggers. The gold standard test is the caffeine halothane contracture test. Genetic testing is possible, but not all mutations are known. Parturients who are susceptible to MH or whose fetuses may be susceptible to MH should receive regional anesthesia or non-triggering anesthetics if general anesthesia is required.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rosenberg H, Davis M, James D, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007;2:21.
Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anesth. 2011;107(1):48–56.
Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010;110(2):498–507.
Baum VC, O’Flaherty JE. Anesthesia for genetic, metabolic, and dysmorphic syndromes of childhood. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2015.
Davies AO. Malignant temperature probe. Can Anaesth Soc J. 1980;27(2):179–80.
Hughes WA, Hughes SC. Hemodynamic effects of prostaglandin E2. Obstet Anesth Dig. 1989;9(3):713–6.
Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80(4):771–9.
Preparing the anesthesia machine for MHS patients [Internet]. Malignant Hyperthermia Association of the United States. http://www.mhaus.org/healthcare-professionals/be-prepared/preparing-the-anesthesia-machine. Accessed 4 Jun 2016.
Foster RN, Boothroyd KP. Cesarean section in a complicated case of central core disease. Anaesthesia. 2008;63(5):544–7.
Hofer IS, Mahoney B, Rebarber A, Beilin Y. An ex utero intrapartum treatment procedure in a patient with a family history of malignant hyperthermia. Int J Obstet Anesth. 2014;22(2):146–8.
Sewall K, Flowerdew RMM, Bromberger P. Severe muscular rigidity at birth: malignant hyperthermia syndrome? Can Anaesth Soc J. 1980;27(3):279–82.
Hersch PE, Matheson KH. Anaesthetic considerations for a possible malignant hyperthermia susceptible fetus. Anaesthesia. 1996;51(1):99.
Parturient with MHS partner [Internet]. Malignant Hyperthermia Association of the United States. 2009. http://www.mhaus.org/healthcare-professionals/mhaus-recommendations/parturient-with-mhs-partner. Accessed 4 Jun 2016
Nanson JK, Sheikh A. Anaesthesia for emergency caesarean section in a parturient with bleeding placenta praevia and a potentially malignant hyperthermia-susceptible fetus. Int J Obstet Anesth. 2000;9(4):276–8.
Girard T, Jöhr M, Schaefer C, Urwyler A. Perinatal diagnosis of malignant hyperthermia susceptibility. Anaesthesiology. 2006;104:1353–4.
Stowell K, Pollock N, Langton E. Parinatal diagnosis of malignant hyperthermia susceptibility. Anaesth Intensive Care. 2007;35(3):454–5.
Krause T, Gerbershagen MU, Fiege M, Weißhorn R, Wappler F. Dantrolene – a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59(4):364–73.
Shin YK, Kim YD, Collea JV, Belcher MD. Effect of dantrolene sodium on contractility of isolated human uterine muscle. Int J Obstet Anesth. 1995;4(4):197–200.
Emergency treatment of an acute MH event [Internet]. Malignant Hyperthermia Association of the United States. http://www.mhaus.org/healthcare-professionals/managing-a-crisis. Accessed 4 Jun 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Menshenina, J.R., Mankowitz, S.K.W. (2018). Malignant Hyperthermia. In: Mankowitz, S. (eds) Consults in Obstetric Anesthesiology. Springer, Cham. https://doi.org/10.1007/978-3-319-59680-8_100
Download citation
DOI: https://doi.org/10.1007/978-3-319-59680-8_100
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59679-2
Online ISBN: 978-3-319-59680-8
eBook Packages: MedicineMedicine (R0)